October 02, 2014 10:58 AM ET

Pharmaceuticals

Company Overview of T-19 Inc

Company Overview

T-19 Inc manufactures and markets pharmaceutical products. The company's flagship product TUBERCIN is an immunostimulant that strengthens the human body's own immune system and assists the body in seeking out and combating cancer cells. The company is based in Honolulu, Hawaii. T-19 Inc is a former subsidiary of Hard to Treat Diseases Inc. Prior to Reverse Merger with Shenzhen Mellow Hope Pharm Industrial Co.

Honolulu, HI 

United States

Key Executives for T-19 Inc

T-19 Inc does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Natural Biologics United States
Cephalon International Holdings, Inc. United States
Hedgepath, LLC United States
Sino Lion (USA), Ltd. United States
NeuroLogic, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact T-19 Inc, please visit www.t-19.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.